Gapping down
In reaction to earnings/guidance:
- MUR -7.1%, MTH -5.7%, TSLA -4.1%, BPOP -3.4%, EW -3.3%, NXGN -3.2%, DOV -2.9%, LEVI -2.7% (also reinstates dividend), TER -2.7% (also authorizes $2 bln share repurchase program), WHR -2.6%, CREE -2.1%, AVT -2%, AAPL -1.9%, CCI -1.8%, REZI -1.5%, SLG -1.4%, SHW -1.2%, MKC -1.1%, CNMD -0.8%, TSCO -0.8%, ABMD -0.8%, SEIC -0.7%, FB -0.6%
Other news:
- ZYME -18.3% (provides update on Phase 1 clinical trial for ZW49)
- PWFL -12.4% (stock offering)
- PUK -8% (provides update on Jackson plan to separate Jackson in Q2 2021 through demerger)
- SRGA -7.2% (prices offering of 25 mln shares of common stock at $1.50 per share)
- PHAS -5.4% (presents data from Phase 1b/2a pilot study of pemziviptadil)
- AMC -4.9% (noteholders elected to convert all $600.0 mln of 2.95% Convertible Senior Secured Notes due 2026 into shares of Class A common stock at conversion price of $13.51 per share)
- CVAC -2.9% (prices follow-on public offering of 5,000,000 common shares at a public offering price of $90.00 per common share)
- AIRG -1.8% (announces nationwide availability of first AirgainConnect platform product)
- LMNL -1.6% (provides update regarding strategy)
- CCI -1.5% (signs new long-term agreement with Verizon to support 5G)
Analyst comments:
- ETRN -4.6% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- FRT -2.9% (downgraded to Sector Perform from Sector Outperform at Scotiabank)
- CPA -2.1% (downgraded to Hold from Buy at Deutsche Bank)
- BBBY -2% (downgraded to Neutral from Buy at BofA Securities)
- ARCO -1.8% (downgraded to Neutral from Outperform at Bradesco BBI)
- BJ -1.6% (downgraded to Hold from Buy at Gordon Haskett)
- KR -1.5% (downgraded to Market Perform from Outperform at Telsey Advisory Group)
- HELE -1.4% (downgraded to Perform from Outperform at Oppenheimer)
- VIAC -1.4% (downgraded to Underperform from Neutral at Credit Suisse)
- EBAY -1.3% (downgraded to Hold from Buy at Deutsche Bank)